TrialLipids in health and disease2024

Phase 1 study of AYP-101 (soybean phosphatidylcholine): safety, pharmacokinetics, and lipid profile effects for reducing submental fat.

Hyun Joon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.